|Last Price$0.91||Day Change (%)74.56%|
|Open Price$0.87||Day Change ($)0.39|
|Day Range0.65–2.00||52-Week Range0.22–7.20|
As of Wed 5/25/2016 4:22:00 PM | USD
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of IMS Health Holdings, Inc. and Encourages Investors to Contact the Firm for Additional Information
FDA Requires Stronger Warnings for Antibiotics' Side Effects
Health Insurers Push to Tie Drug Prices to Outcomes
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.